A Rare Case of CLN3-associated Isolated Retinal Degeneration with Macular Oedema

Dimitrios Kalogeropoulos; Samir Khandhadia; Fatima Shawkat; Andrew John Lotery

doi:10.1055/a-2577-9808

Klinische Monatsblätter für Augenheilkunde, Table of Contents

Klin Monbl Augenheilkd
DOI: 10.1055/a-2577-9808

Der interessante Fall

A Rare Case of CLN3-associated Isolated Retinal Degeneration with Macular Oedema

Ein seltener Fall von CLN3-assoziierter isolierter Netzhautdegeneration mit Makulaödem

Dimitrios Kalogeropoulos

¹Southampton Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain and Northern Ireland

,

Samir Khandhadia

¹Southampton Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain and Northern Ireland

,

Fatima Shawkat

¹Southampton Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain and Northern Ireland

,

Andrew John Lotery

¹Southampton Eye Unit, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom of Great Britain and Northern Ireland

²Faculty of Medicine, University of Southampton, Southampton, United Kingdom of Great Britain and Northern Ireland

› Author Affiliations

Abstract

Full Text

References

References
1 Johnson TB, Cain JT, White KA. Therapeutic landscape for Batten disease: current treatments and future prospects. Nat Rev Neurol 2019; 15: 161-178
2 Licchetta L, Bisulli F, Fietz M. A novel mutation of Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy. Eur J Med Genet 2015; 58: 540-544
3 Mink JW, Augustine EF, Adams HR. Classification and natural history of the neuronal ceroid lipofuscinoses. J Child Neurol 2013; 28: 1101-1105
4 Mole SE, Williams RE, Goebel HH. Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. Neurogenetics 2005; 6: 107-126
5 Kousi M, Lehesjoki AE, Mole SE. Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses. Hum Mutat 2012; 33: 42-63
6 Ku CA, Hull S, Arno G. Detailed clinical phenotype and molecular genetic findings in CLN3-associated isolated retinal degeneration. JAMA Ophthalmol 2017; 135: 749-760
7 Weisschuh N, Mayer AK, Strom TM. et al. Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing. PLoS One 2016; 11: e0145951
8 Mole SE, Anderson G, Band HA. Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 2019; 18: 107-116
9 Pichi F, Abboud EB, Ghazi NG. et al. Fundus autofluorescence imaging in hereditary retinal diseases. Acta Ophthalmol 2018; 96: e561-e561
10 Smirnov VM, Nassisi M, Solis Hernandez C. et al. Retinal Phenotype of Patients With Isolated Retinal Degeneration Due to CLN3 Pathogenic Variants in a French Retinitis Pigmentosa Cohort. JAMA Ophthalmol 2021; 139: 278-291
11 Schulz A, Ajayi T, Specchio N. Study of intraventricular Cerliponase Alfa for CLN2 disease. N Engl J Med 2018; 378: 1898-1907
12 Dulz S, Schwering C, Wildner J. et al. Ongoing retinal degeneration despite intraventricular enzyme replacement therapy with cerliponase alfa in late-infantile neuronal ceroid lipofuscinosis type 2 (CLN2 disease). Br J Ophthalmol 2023; 107: 1478-1483
13 Collins J, Holder GE, Herbert H. et al. Batten disease: features to facilitate early diagnosis. Br J Ophthalmol 2006; 90: 1119-1124